Upregulation of antioxidant thioredoxin by antidepressants fluoxetine and venlafaxine

Authors:

Abstract
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are the most commonly used drugs for the treatment of depression. Studies have shown that chronic treatment with SSRIs and SNRIs produces a protective effect against oxidative stress. Thioredoxin (Trx) is an antioxidant protein that reverses protein cysteine oxidation and facilitates scavenging reactive oxygen species.
Funding Information
  • Brain and Behavior Research Foundation (24691)

This publication has 39 references indexed in Scilit: